Netherland: CCMO announces conditions for (re)starting clinical trials in clinical research units

2020-05-27T08:41:26+00:00May 27th, 2020|Categories: Clinical Trial, Covid-19, Europe, Western Europe|Tags: , , , |0 Comments

The Central Committee on Research Involving Human Subjects (CCMO) published a document with the conditions for the (re)start of studies in clinical research units. The document foresees a step-by-step relaxation of the restrictive measures.

This makes it possible to restart studies that were put on hold in phase I clinics or to start new studies if the conditions described in the document are met.

The conditions apply not only to phase I clinics but to all clinical research units (CRU).

For more details, please see the guidance document from CCMO.

Meditrial can help – Contact us for immediate support

Meditrial has developed rapid workflows to conduct risk assessment, implement rescue plans and execute solutions for ongoing clinical trials:

Contact Meditrial for immediate assistance in Europe or the US.

Free Helpline +1-800-901-4286

Leave A Comment

Go to Top